Section 5: Patient Safety and Quality Assurance

5PSQ-137

WHEN IS A DRUG INTERACTION NOT A DRUG INTERACTION? COMPARISON OF DRUG-DRUG INTERACTIONS-CHECKING DATABASES BETWEEN THE UK AND USA

5PSQ-136

A PHARMACEUTICAL CARE PROGRAMME IN PATIENTS UNDERGOING CARDIAC SURGERY

5PSQ-135

SAFETY RELATED TO PSYCHOGERIATRIC PATIENTS. ONE-YEAR PROSPECTIVE STUDY

5PSQ-134

ANALYSIS OF MEDICATION DISCREPANCIES AS PART OF THE CLINICAL PHARMACY MEDICATION RECONCILIATION PROCESS

5PSQ-133

DRUG-RELATED HOSPITAL ADMISSIONS IN AN ACUTE GERIATRIC UNIT AND ASSOCIATED FACTORS

5PSQ-132

ASSOCIATION BETWEEN ANTICHOLINERGIC BURDEN OF MEDICATIONS AND MORTALITY IN OLDER ADULTS: A SYSTEMATIC REVIEW

5PSQ-131

PHARMACOVIGILANCE 2018: SURVEY ON THE PERCEPTION OF PHARMACOVIGILANCE IN THE HOSPITAL - TOOLS TO ENHANCE ADVERSE DRUG REACTIONS REPORTING

5PSQ-130

ANALYSIS OF RITUXIMAB OFF-LABEL USE

5PSQ-129

BALANCE AND CLASSIFICATION OF PHARMACEUTICAL INTERVENTIONS IN A GENERAL HOSPITAL OF SPECIALTIES: THE PERSONALISED HOSPITAL PHARMACY

5PSQ-128

PHARMACOTHERAPEUTIC PROFILE AND RISK OF DRUG-RELATED PROBLEMS AND DRUG INTERACTIONS IN HIV+ PATIENTS OF A HEALTH AREA

5PSQ-127

DISPENSATION OF FINITE MEDICATION AT DISCHARGE IN THE COMPLEX CHRONIC PATIENT

5PSQ-126

MEDICATIONS AND FALLS IN THE ELDERLY: AN EPIDEMIOLOGICAL STUDY IN A FRENCH HOSPITAL

5PSQ-125

QUALITY AND RISK MANAGEMENT IN HOSPITALS : EVALUATION OF IMPLANTABLE MEDICAL DEVICES’ TRACEABILITY PROCESS

5PSQ-124

ABSTRACT WITHDRAWN

5PSQ-123

FAILURE MODES, EFFECTS AND CRITICALITY ANALYSIS: APPLICATION TO A HOSPITAL PHARMACY

Pages